"10.1371_journal.pone.0048959","plos one","2012-11-08T00:00:00Z","Antonio Rivero-Juárez; Luis F Lopez-Cortes; Angela Camacho; Almudena Torres-Cornejo; Juan A Pineda; Manuel Marquez-Solero; Antonio Caruz; Rosa Ruiz-Valderas; Julian Torre-Cisneros; Alicia Gutierrez-Valencia; Antonio Rivero","Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Cordoba, Spain; Maimonides Institute for Biomedical Research, Cordoba, Spain; Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain; Unit of Infectious Diseases, Hospital Universitario de Valme, Seville, Spain; Unit of Infectious Diseases, Hospital Universitario Virgen de la Victoria, Malaga, Spain; Immunogenetics Unit, Faculty of Sciences, Universidad de Jaén, Jaen, Spain","Conceived and designed the experiments: ARJ LFLC AR. Performed the experiments: ARJ LFLC JAP A. Camacho MMS AR. Analyzed the data: ARJ AR. Contributed reagents/materials/analysis tools: AR ARJ LFLC A. Camacho ATC JAP MMS A. Caruz RRV JTC AGV. Wrote the paper: ARJ AR. Critical discussion of the manuscript: AR ARJ LFLC A. Camacho ATC JAP MMS A. Caruz RRV JTC AGV.","AR has received consulting fees from Bristol-Myers Squibb, Abbott, Gilead, Roche and Boehringer Ingelheim. JAP has received consulting fees from GlaxoSmithKline, Bristol-Myers Squibb, Abbott, Gilead, Merck Sharp & Dohme, Janssen-Cilag and Boehringer Ingelheim. LFLC has received funds for speaking at symposia organized on behalf of Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithkline, Gilead Sciences, MSD, Janssen-Cilag S. A., and Viiv Healthcare. They have received research support from GlaxoSmithKline, Roche, Bristol-Myers Squibb, Schering-Plough, Abbott and Boehringer Ingelheim, and lecture fees from GlaxoSmithKline, Roche, Abbott, Bristol-Myers Squibb, Boehringer Ingelheim and Schering-Plough. The remaining authors have no conflicts of interest to declare. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2012","11","Antonio Rivero-Juárez","ARJ",11,TRUE,3,4,2,2,TRUE,TRUE,TRUE,3,"6;8;9",TRUE
